H5
General Information
DRACP ID DRACP02433
Peptide Name H5
Sequence KRKIKRK
Sequence Length 7
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
U-937 | Adult acute monocytic leukemi; Acute monoblastic/monocytic leukemia | Leukemia | LD50>64 µM; MTC>64 µM | CytoTox 96 non-radiactive cytotoxicity assay | 2 h | 1 |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C42H85N17O8
Absent amino acids ACDEFGHLMNPQSTVWY
Common amino acids K
Mass 106344
Pl 12.56
Basic residues 6
Acidic residues 0
Hydrophobic residues 1
Net charge 6
Boman Index -4712
Hydrophobicity -287.14
Aliphatic Index 55.71
Half Life
Mammalian: 1.3 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 0
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 25192319
Title Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties
Year 2014
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPS_9139